The UK’s pharma deal was vital – but the GSK boss is right about US dominance | Nils Pratley
That’s gratitude, eh? It’s not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the boss of GSK, Britain’s second largest pharma firm, to extol the virtues of doing business in the US. The US is “still the leading market in the world in…